Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Dec 09 2020

· Issued by Aurobindo Pharma Ltd

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-09-2020-6

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 09, 2020, titled "Press Release on USFDA approval for Dexmedetomidine HCL in 0.9% Sodium Chloride Injection".

View Attachment

6ix hasn’t read this filing yet.

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases